%0 Journal Article %T Benefit of everolimus as a monotherapy for a refractory breast cancer patient bearing multiple genetic mutations in the PI3K/AKT/mTOR signaling pathway %A Jinpu Yu %A Lei Han %A Pengpeng Liu %A Weipeng Zhao %A Wenwen Zhang %A Yanan Cheng %A Yehui Shi %A Yingnan Ye %A Zhongsheng Tong %J Archive of "Cancer Biology & Medicine". %D 2018 %R 10.20892/j.issn.2095-3941.2017.0188 %K Breast cancer %K everolimus %K next-generation sequencing %K liquid biopsy %K PI3K/AKT/mTOR %U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6121052/